Obsessive-Compulsive Disorder Drugs Market, Global Outlook and Forecast 2022-2028
Obsessive–compulsive disorder (OCD) is a mental disorder in which a person feels the need to perform certain routines repeatedly (called 'compulsions'), or has certain thoughts repeatedly (called 'obsessions').
This report contains market size and forecasts of Obsessive-Compulsive Disorder Drugs in Global, including the following market information:
Global Obsessive-Compulsive Disorder Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Obsessive-Compulsive Disorder Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
SSRI Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Obsessive-Compulsive Disorder Drugs include Eli Lilly and Co., GlaxoSmithKline Plc, H. Lundbeck AS, Novartis AG and Pfizer Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Obsessive-Compulsive Disorder Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Obsessive-Compulsive Disorder Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Obsessive-Compulsive Disorder Drugs Market Segment Percentages, by Type, 2021 (%)
Global Obsessive-Compulsive Disorder Drugs Market Segment Percentages, by Application, 2021 (%)
Global Obsessive-Compulsive Disorder Drugs Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Obsessive-Compulsive Disorder Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Obsessive-Compulsive Disorder Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of Obsessive-Compulsive Disorder Drugs in Global, including the following market information:
Global Obsessive-Compulsive Disorder Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Obsessive-Compulsive Disorder Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
SSRI Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Obsessive-Compulsive Disorder Drugs include Eli Lilly and Co., GlaxoSmithKline Plc, H. Lundbeck AS, Novartis AG and Pfizer Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Obsessive-Compulsive Disorder Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Obsessive-Compulsive Disorder Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Obsessive-Compulsive Disorder Drugs Market Segment Percentages, by Type, 2021 (%)
- SSRI
- TCA
- Others
Global Obsessive-Compulsive Disorder Drugs Market Segment Percentages, by Application, 2021 (%)
- Hospital
- Clinic
- Research Institute
- Other
Global Obsessive-Compulsive Disorder Drugs Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Obsessive-Compulsive Disorder Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Obsessive-Compulsive Disorder Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Eli Lilly and Co.
- GlaxoSmithKline Plc
- H. Lundbeck AS
- Novartis AG
- Pfizer Inc.
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Obsessive-Compulsive Disorder Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Obsessive-Compulsive Disorder Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL OBSESSIVE-COMPULSIVE DISORDER DRUGS OVERALL MARKET SIZE
2.1 Global Obsessive-Compulsive Disorder Drugs Market Size: 2021 VS 2028
2.2 Global Obsessive-Compulsive Disorder Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Obsessive-Compulsive Disorder Drugs Players in Global Market
3.2 Top Global Obsessive-Compulsive Disorder Drugs Companies Ranked by Revenue
3.3 Global Obsessive-Compulsive Disorder Drugs Revenue by Companies
3.4 Top 3 and Top 5 Obsessive-Compulsive Disorder Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Obsessive-Compulsive Disorder Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Obsessive-Compulsive Disorder Drugs Players in Global Market
3.6.1 List of Global Tier 1 Obsessive-Compulsive Disorder Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Obsessive-Compulsive Disorder Drugs Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 by Type - Global Obsessive-Compulsive Disorder Drugs Market Size Markets, 2021 & 2028
4.1.2 SSRI
4.1.3 TCA
4.1.4 Others
4.2 By Type - Global Obsessive-Compulsive Disorder Drugs Revenue & Forecasts
4.2.1 By Type - Global Obsessive-Compulsive Disorder Drugs Revenue, 2017-2022
4.2.2 By Type - Global Obsessive-Compulsive Disorder Drugs Revenue, 2023-2028
4.2.3 By Type - Global Obsessive-Compulsive Disorder Drugs Revenue Market Share, 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Obsessive-Compulsive Disorder Drugs Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Research Institute
5.1.5 Other
5.2 By Application - Global Obsessive-Compulsive Disorder Drugs Revenue & Forecasts
5.2.1 By Application - Global Obsessive-Compulsive Disorder Drugs Revenue, 2017-2022
5.2.2 By Application - Global Obsessive-Compulsive Disorder Drugs Revenue, 2023-2028
5.2.3 By Application - Global Obsessive-Compulsive Disorder Drugs Revenue Market Share, 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Obsessive-Compulsive Disorder Drugs Market Size, 2021 & 2028
6.2 By Region - Global Obsessive-Compulsive Disorder Drugs Revenue & Forecasts
6.2.1 By Region - Global Obsessive-Compulsive Disorder Drugs Revenue, 2017-2022
6.2.2 By Region - Global Obsessive-Compulsive Disorder Drugs Revenue, 2023-2028
6.2.3 By Region - Global Obsessive-Compulsive Disorder Drugs Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Obsessive-Compulsive Disorder Drugs Revenue, 2017-2028
6.3.2 US Obsessive-Compulsive Disorder Drugs Market Size, 2017-2028
6.3.3 Canada Obsessive-Compulsive Disorder Drugs Market Size, 2017-2028
6.3.4 Mexico Obsessive-Compulsive Disorder Drugs Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Obsessive-Compulsive Disorder Drugs Revenue, 2017-2028
6.4.2 Germany Obsessive-Compulsive Disorder Drugs Market Size, 2017-2028
6.4.3 France Obsessive-Compulsive Disorder Drugs Market Size, 2017-2028
6.4.4 U.K. Obsessive-Compulsive Disorder Drugs Market Size, 2017-2028
6.4.5 Italy Obsessive-Compulsive Disorder Drugs Market Size, 2017-2028
6.4.6 Russia Obsessive-Compulsive Disorder Drugs Market Size, 2017-2028
6.4.7 Nordic Countries Obsessive-Compulsive Disorder Drugs Market Size, 2017-2028
6.4.8 Benelux Obsessive-Compulsive Disorder Drugs Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Obsessive-Compulsive Disorder Drugs Revenue, 2017-2028
6.5.2 China Obsessive-Compulsive Disorder Drugs Market Size, 2017-2028
6.5.3 Japan Obsessive-Compulsive Disorder Drugs Market Size, 2017-2028
6.5.4 South Korea Obsessive-Compulsive Disorder Drugs Market Size, 2017-2028
6.5.5 Southeast Asia Obsessive-Compulsive Disorder Drugs Market Size, 2017-2028
6.5.6 India Obsessive-Compulsive Disorder Drugs Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Obsessive-Compulsive Disorder Drugs Revenue, 2017-2028
6.6.2 Brazil Obsessive-Compulsive Disorder Drugs Market Size, 2017-2028
6.6.3 Argentina Obsessive-Compulsive Disorder Drugs Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Obsessive-Compulsive Disorder Drugs Revenue, 2017-2028
6.7.2 Turkey Obsessive-Compulsive Disorder Drugs Market Size, 2017-2028
6.7.3 Israel Obsessive-Compulsive Disorder Drugs Market Size, 2017-2028
6.7.4 Saudi Arabia Obsessive-Compulsive Disorder Drugs Market Size, 2017-2028
6.7.5 UAE Obsessive-Compulsive Disorder Drugs Market Size, 2017-2028
7 PLAYERS PROFILES
7.1 Eli Lilly and Co.
7.1.1 Eli Lilly and Co. Corporate Summary
7.1.2 Eli Lilly and Co. Business Overview
7.1.3 Eli Lilly and Co. Obsessive-Compulsive Disorder Drugs Major Product Offerings
7.1.4 Eli Lilly and Co. Obsessive-Compulsive Disorder Drugs Revenue in Global Market (2017-2022)
7.1.5 Eli Lilly and Co. Key News
7.2 GlaxoSmithKline Plc
7.2.1 GlaxoSmithKline Plc Corporate Summary
7.2.2 GlaxoSmithKline Plc Business Overview
7.2.3 GlaxoSmithKline Plc Obsessive-Compulsive Disorder Drugs Major Product Offerings
7.2.4 GlaxoSmithKline Plc Obsessive-Compulsive Disorder Drugs Revenue in Global Market (2017-2022)
7.2.5 GlaxoSmithKline Plc Key News
7.3 H. Lundbeck AS
7.3.1 H. Lundbeck AS Corporate Summary
7.3.2 H. Lundbeck AS Business Overview
7.3.3 H. Lundbeck AS Obsessive-Compulsive Disorder Drugs Major Product Offerings
7.3.4 H. Lundbeck AS Obsessive-Compulsive Disorder Drugs Revenue in Global Market (2017-2022)
7.3.5 H. Lundbeck AS Key News
7.4 Novartis AG
7.4.1 Novartis AG Corporate Summary
7.4.2 Novartis AG Business Overview
7.4.3 Novartis AG Obsessive-Compulsive Disorder Drugs Major Product Offerings
7.4.4 Novartis AG Obsessive-Compulsive Disorder Drugs Revenue in Global Market (2017-2022)
7.4.5 Novartis AG Key News
7.5 Pfizer Inc.
7.5.1 Pfizer Inc. Corporate Summary
7.5.2 Pfizer Inc. Business Overview
7.5.3 Pfizer Inc. Obsessive-Compulsive Disorder Drugs Major Product Offerings
7.5.4 Pfizer Inc. Obsessive-Compulsive Disorder Drugs Revenue in Global Market (2017-2022)
7.5.5 Pfizer Inc. Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
1.1 Obsessive-Compulsive Disorder Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Obsessive-Compulsive Disorder Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL OBSESSIVE-COMPULSIVE DISORDER DRUGS OVERALL MARKET SIZE
2.1 Global Obsessive-Compulsive Disorder Drugs Market Size: 2021 VS 2028
2.2 Global Obsessive-Compulsive Disorder Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Obsessive-Compulsive Disorder Drugs Players in Global Market
3.2 Top Global Obsessive-Compulsive Disorder Drugs Companies Ranked by Revenue
3.3 Global Obsessive-Compulsive Disorder Drugs Revenue by Companies
3.4 Top 3 and Top 5 Obsessive-Compulsive Disorder Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Obsessive-Compulsive Disorder Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Obsessive-Compulsive Disorder Drugs Players in Global Market
3.6.1 List of Global Tier 1 Obsessive-Compulsive Disorder Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Obsessive-Compulsive Disorder Drugs Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 by Type - Global Obsessive-Compulsive Disorder Drugs Market Size Markets, 2021 & 2028
4.1.2 SSRI
4.1.3 TCA
4.1.4 Others
4.2 By Type - Global Obsessive-Compulsive Disorder Drugs Revenue & Forecasts
4.2.1 By Type - Global Obsessive-Compulsive Disorder Drugs Revenue, 2017-2022
4.2.2 By Type - Global Obsessive-Compulsive Disorder Drugs Revenue, 2023-2028
4.2.3 By Type - Global Obsessive-Compulsive Disorder Drugs Revenue Market Share, 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Obsessive-Compulsive Disorder Drugs Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Research Institute
5.1.5 Other
5.2 By Application - Global Obsessive-Compulsive Disorder Drugs Revenue & Forecasts
5.2.1 By Application - Global Obsessive-Compulsive Disorder Drugs Revenue, 2017-2022
5.2.2 By Application - Global Obsessive-Compulsive Disorder Drugs Revenue, 2023-2028
5.2.3 By Application - Global Obsessive-Compulsive Disorder Drugs Revenue Market Share, 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Obsessive-Compulsive Disorder Drugs Market Size, 2021 & 2028
6.2 By Region - Global Obsessive-Compulsive Disorder Drugs Revenue & Forecasts
6.2.1 By Region - Global Obsessive-Compulsive Disorder Drugs Revenue, 2017-2022
6.2.2 By Region - Global Obsessive-Compulsive Disorder Drugs Revenue, 2023-2028
6.2.3 By Region - Global Obsessive-Compulsive Disorder Drugs Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Obsessive-Compulsive Disorder Drugs Revenue, 2017-2028
6.3.2 US Obsessive-Compulsive Disorder Drugs Market Size, 2017-2028
6.3.3 Canada Obsessive-Compulsive Disorder Drugs Market Size, 2017-2028
6.3.4 Mexico Obsessive-Compulsive Disorder Drugs Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Obsessive-Compulsive Disorder Drugs Revenue, 2017-2028
6.4.2 Germany Obsessive-Compulsive Disorder Drugs Market Size, 2017-2028
6.4.3 France Obsessive-Compulsive Disorder Drugs Market Size, 2017-2028
6.4.4 U.K. Obsessive-Compulsive Disorder Drugs Market Size, 2017-2028
6.4.5 Italy Obsessive-Compulsive Disorder Drugs Market Size, 2017-2028
6.4.6 Russia Obsessive-Compulsive Disorder Drugs Market Size, 2017-2028
6.4.7 Nordic Countries Obsessive-Compulsive Disorder Drugs Market Size, 2017-2028
6.4.8 Benelux Obsessive-Compulsive Disorder Drugs Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Obsessive-Compulsive Disorder Drugs Revenue, 2017-2028
6.5.2 China Obsessive-Compulsive Disorder Drugs Market Size, 2017-2028
6.5.3 Japan Obsessive-Compulsive Disorder Drugs Market Size, 2017-2028
6.5.4 South Korea Obsessive-Compulsive Disorder Drugs Market Size, 2017-2028
6.5.5 Southeast Asia Obsessive-Compulsive Disorder Drugs Market Size, 2017-2028
6.5.6 India Obsessive-Compulsive Disorder Drugs Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Obsessive-Compulsive Disorder Drugs Revenue, 2017-2028
6.6.2 Brazil Obsessive-Compulsive Disorder Drugs Market Size, 2017-2028
6.6.3 Argentina Obsessive-Compulsive Disorder Drugs Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Obsessive-Compulsive Disorder Drugs Revenue, 2017-2028
6.7.2 Turkey Obsessive-Compulsive Disorder Drugs Market Size, 2017-2028
6.7.3 Israel Obsessive-Compulsive Disorder Drugs Market Size, 2017-2028
6.7.4 Saudi Arabia Obsessive-Compulsive Disorder Drugs Market Size, 2017-2028
6.7.5 UAE Obsessive-Compulsive Disorder Drugs Market Size, 2017-2028
7 PLAYERS PROFILES
7.1 Eli Lilly and Co.
7.1.1 Eli Lilly and Co. Corporate Summary
7.1.2 Eli Lilly and Co. Business Overview
7.1.3 Eli Lilly and Co. Obsessive-Compulsive Disorder Drugs Major Product Offerings
7.1.4 Eli Lilly and Co. Obsessive-Compulsive Disorder Drugs Revenue in Global Market (2017-2022)
7.1.5 Eli Lilly and Co. Key News
7.2 GlaxoSmithKline Plc
7.2.1 GlaxoSmithKline Plc Corporate Summary
7.2.2 GlaxoSmithKline Plc Business Overview
7.2.3 GlaxoSmithKline Plc Obsessive-Compulsive Disorder Drugs Major Product Offerings
7.2.4 GlaxoSmithKline Plc Obsessive-Compulsive Disorder Drugs Revenue in Global Market (2017-2022)
7.2.5 GlaxoSmithKline Plc Key News
7.3 H. Lundbeck AS
7.3.1 H. Lundbeck AS Corporate Summary
7.3.2 H. Lundbeck AS Business Overview
7.3.3 H. Lundbeck AS Obsessive-Compulsive Disorder Drugs Major Product Offerings
7.3.4 H. Lundbeck AS Obsessive-Compulsive Disorder Drugs Revenue in Global Market (2017-2022)
7.3.5 H. Lundbeck AS Key News
7.4 Novartis AG
7.4.1 Novartis AG Corporate Summary
7.4.2 Novartis AG Business Overview
7.4.3 Novartis AG Obsessive-Compulsive Disorder Drugs Major Product Offerings
7.4.4 Novartis AG Obsessive-Compulsive Disorder Drugs Revenue in Global Market (2017-2022)
7.4.5 Novartis AG Key News
7.5 Pfizer Inc.
7.5.1 Pfizer Inc. Corporate Summary
7.5.2 Pfizer Inc. Business Overview
7.5.3 Pfizer Inc. Obsessive-Compulsive Disorder Drugs Major Product Offerings
7.5.4 Pfizer Inc. Obsessive-Compulsive Disorder Drugs Revenue in Global Market (2017-2022)
7.5.5 Pfizer Inc. Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES
Table 1. Obsessive-Compulsive Disorder Drugs Market Opportunities & Trends in Global Market
Table 2. Obsessive-Compulsive Disorder Drugs Market Drivers in Global Market
Table 3. Obsessive-Compulsive Disorder Drugs Market Restraints in Global Market
Table 4. Key Players of Obsessive-Compulsive Disorder Drugs in Global Market
Table 5. Top Obsessive-Compulsive Disorder Drugs Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Obsessive-Compulsive Disorder Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Obsessive-Compulsive Disorder Drugs Revenue Share by Companies, 2017-2022
Table 8. Global Companies Obsessive-Compulsive Disorder Drugs Product Type
Table 9. List of Global Tier 1 Obsessive-Compulsive Disorder Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Obsessive-Compulsive Disorder Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Obsessive-Compulsive Disorder Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Obsessive-Compulsive Disorder Drugs Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Obsessive-Compulsive Disorder Drugs Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Obsessive-Compulsive Disorder Drugs Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Obsessive-Compulsive Disorder Drugs Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Obsessive-Compulsive Disorder Drugs Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Obsessive-Compulsive Disorder Drugs Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Obsessive-Compulsive Disorder Drugs Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Obsessive-Compulsive Disorder Drugs Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Obsessive-Compulsive Disorder Drugs Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Obsessive-Compulsive Disorder Drugs Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Obsessive-Compulsive Disorder Drugs Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Obsessive-Compulsive Disorder Drugs Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Obsessive-Compulsive Disorder Drugs Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Obsessive-Compulsive Disorder Drugs Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Obsessive-Compulsive Disorder Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Obsessive-Compulsive Disorder Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Obsessive-Compulsive Disorder Drugs Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Obsessive-Compulsive Disorder Drugs Revenue, (US$, Mn), 2023-2028
Table 30. Eli Lilly and Co. Corporate Summary
Table 31. Eli Lilly and Co. Obsessive-Compulsive Disorder Drugs Product Offerings
Table 32. Eli Lilly and Co. Obsessive-Compulsive Disorder Drugs Revenue (US$, Mn), (2017-2022)
Table 33. GlaxoSmithKline Plc Corporate Summary
Table 34. GlaxoSmithKline Plc Obsessive-Compulsive Disorder Drugs Product Offerings
Table 35. GlaxoSmithKline Plc Obsessive-Compulsive Disorder Drugs Revenue (US$, Mn), (2017-2022)
Table 36. H. Lundbeck AS Corporate Summary
Table 37. H. Lundbeck AS Obsessive-Compulsive Disorder Drugs Product Offerings
Table 38. H. Lundbeck AS Obsessive-Compulsive Disorder Drugs Revenue (US$, Mn), (2017-2022)
Table 39. Novartis AG Corporate Summary
Table 40. Novartis AG Obsessive-Compulsive Disorder Drugs Product Offerings
Table 41. Novartis AG Obsessive-Compulsive Disorder Drugs Revenue (US$, Mn), (2017-2022)
Table 42. Pfizer Inc. Corporate Summary
Table 43. Pfizer Inc. Obsessive-Compulsive Disorder Drugs Product Offerings
Table 44. Pfizer Inc. Obsessive-Compulsive Disorder Drugs Revenue (US$, Mn), (2017-2022)
Table 1. Obsessive-Compulsive Disorder Drugs Market Opportunities & Trends in Global Market
Table 2. Obsessive-Compulsive Disorder Drugs Market Drivers in Global Market
Table 3. Obsessive-Compulsive Disorder Drugs Market Restraints in Global Market
Table 4. Key Players of Obsessive-Compulsive Disorder Drugs in Global Market
Table 5. Top Obsessive-Compulsive Disorder Drugs Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Obsessive-Compulsive Disorder Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Obsessive-Compulsive Disorder Drugs Revenue Share by Companies, 2017-2022
Table 8. Global Companies Obsessive-Compulsive Disorder Drugs Product Type
Table 9. List of Global Tier 1 Obsessive-Compulsive Disorder Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Obsessive-Compulsive Disorder Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Obsessive-Compulsive Disorder Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Obsessive-Compulsive Disorder Drugs Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Obsessive-Compulsive Disorder Drugs Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Obsessive-Compulsive Disorder Drugs Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Obsessive-Compulsive Disorder Drugs Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Obsessive-Compulsive Disorder Drugs Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Obsessive-Compulsive Disorder Drugs Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Obsessive-Compulsive Disorder Drugs Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Obsessive-Compulsive Disorder Drugs Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Obsessive-Compulsive Disorder Drugs Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Obsessive-Compulsive Disorder Drugs Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Obsessive-Compulsive Disorder Drugs Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Obsessive-Compulsive Disorder Drugs Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Obsessive-Compulsive Disorder Drugs Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Obsessive-Compulsive Disorder Drugs Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Obsessive-Compulsive Disorder Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Obsessive-Compulsive Disorder Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Obsessive-Compulsive Disorder Drugs Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Obsessive-Compulsive Disorder Drugs Revenue, (US$, Mn), 2023-2028
Table 30. Eli Lilly and Co. Corporate Summary
Table 31. Eli Lilly and Co. Obsessive-Compulsive Disorder Drugs Product Offerings
Table 32. Eli Lilly and Co. Obsessive-Compulsive Disorder Drugs Revenue (US$, Mn), (2017-2022)
Table 33. GlaxoSmithKline Plc Corporate Summary
Table 34. GlaxoSmithKline Plc Obsessive-Compulsive Disorder Drugs Product Offerings
Table 35. GlaxoSmithKline Plc Obsessive-Compulsive Disorder Drugs Revenue (US$, Mn), (2017-2022)
Table 36. H. Lundbeck AS Corporate Summary
Table 37. H. Lundbeck AS Obsessive-Compulsive Disorder Drugs Product Offerings
Table 38. H. Lundbeck AS Obsessive-Compulsive Disorder Drugs Revenue (US$, Mn), (2017-2022)
Table 39. Novartis AG Corporate Summary
Table 40. Novartis AG Obsessive-Compulsive Disorder Drugs Product Offerings
Table 41. Novartis AG Obsessive-Compulsive Disorder Drugs Revenue (US$, Mn), (2017-2022)
Table 42. Pfizer Inc. Corporate Summary
Table 43. Pfizer Inc. Obsessive-Compulsive Disorder Drugs Product Offerings
Table 44. Pfizer Inc. Obsessive-Compulsive Disorder Drugs Revenue (US$, Mn), (2017-2022)
LIST OF FIGURES
Figure 1. Obsessive-Compulsive Disorder Drugs Segment by Type in 2021
Figure 2. Obsessive-Compulsive Disorder Drugs Segment by Application in 2021
Figure 3. Global Obsessive-Compulsive Disorder Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Obsessive-Compulsive Disorder Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Obsessive-Compulsive Disorder Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Obsessive-Compulsive Disorder Drugs Revenue in 2021
Figure 8. By Type - Global Obsessive-Compulsive Disorder Drugs Revenue Market Share, 2017-2028
Figure 9. By Application - Global Obsessive-Compulsive Disorder Drugs Revenue Market Share, 2017-2028
Figure 10. By Region - Global Obsessive-Compulsive Disorder Drugs Revenue Market Share, 2017-2028
Figure 11. By Country - North America Obsessive-Compulsive Disorder Drugs Revenue Market Share, 2017-2028
Figure 12. US Obsessive-Compulsive Disorder Drugs Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Obsessive-Compulsive Disorder Drugs Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Obsessive-Compulsive Disorder Drugs Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Obsessive-Compulsive Disorder Drugs Revenue Market Share, 2017-2028
Figure 16. Germany Obsessive-Compulsive Disorder Drugs Revenue, (US$, Mn), 2017-2028
Figure 17. France Obsessive-Compulsive Disorder Drugs Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Obsessive-Compulsive Disorder Drugs Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Obsessive-Compulsive Disorder Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Obsessive-Compulsive Disorder Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Obsessive-Compulsive Disorder Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Obsessive-Compulsive Disorder Drugs Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Obsessive-Compulsive Disorder Drugs Revenue Market Share, 2017-2028
Figure 24. China Obsessive-Compulsive Disorder Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Obsessive-Compulsive Disorder Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Obsessive-Compulsive Disorder Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Obsessive-Compulsive Disorder Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. India Obsessive-Compulsive Disorder Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Obsessive-Compulsive Disorder Drugs Revenue Market Share, 2017-2028
Figure 30. Brazil Obsessive-Compulsive Disorder Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Obsessive-Compulsive Disorder Drugs Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Obsessive-Compulsive Disorder Drugs Revenue Market Share, 2017-2028
Figure 33. Turkey Obsessive-Compulsive Disorder Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Obsessive-Compulsive Disorder Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Obsessive-Compulsive Disorder Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Obsessive-Compulsive Disorder Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. Eli Lilly and Co. Obsessive-Compulsive Disorder Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. GlaxoSmithKline Plc Obsessive-Compulsive Disorder Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. H. Lundbeck AS Obsessive-Compulsive Disorder Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Novartis AG Obsessive-Compulsive Disorder Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Pfizer Inc. Obsessive-Compulsive Disorder Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 1. Obsessive-Compulsive Disorder Drugs Segment by Type in 2021
Figure 2. Obsessive-Compulsive Disorder Drugs Segment by Application in 2021
Figure 3. Global Obsessive-Compulsive Disorder Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Obsessive-Compulsive Disorder Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Obsessive-Compulsive Disorder Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Obsessive-Compulsive Disorder Drugs Revenue in 2021
Figure 8. By Type - Global Obsessive-Compulsive Disorder Drugs Revenue Market Share, 2017-2028
Figure 9. By Application - Global Obsessive-Compulsive Disorder Drugs Revenue Market Share, 2017-2028
Figure 10. By Region - Global Obsessive-Compulsive Disorder Drugs Revenue Market Share, 2017-2028
Figure 11. By Country - North America Obsessive-Compulsive Disorder Drugs Revenue Market Share, 2017-2028
Figure 12. US Obsessive-Compulsive Disorder Drugs Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Obsessive-Compulsive Disorder Drugs Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Obsessive-Compulsive Disorder Drugs Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Obsessive-Compulsive Disorder Drugs Revenue Market Share, 2017-2028
Figure 16. Germany Obsessive-Compulsive Disorder Drugs Revenue, (US$, Mn), 2017-2028
Figure 17. France Obsessive-Compulsive Disorder Drugs Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Obsessive-Compulsive Disorder Drugs Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Obsessive-Compulsive Disorder Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Obsessive-Compulsive Disorder Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Obsessive-Compulsive Disorder Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Obsessive-Compulsive Disorder Drugs Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Obsessive-Compulsive Disorder Drugs Revenue Market Share, 2017-2028
Figure 24. China Obsessive-Compulsive Disorder Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Obsessive-Compulsive Disorder Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Obsessive-Compulsive Disorder Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Obsessive-Compulsive Disorder Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. India Obsessive-Compulsive Disorder Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Obsessive-Compulsive Disorder Drugs Revenue Market Share, 2017-2028
Figure 30. Brazil Obsessive-Compulsive Disorder Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Obsessive-Compulsive Disorder Drugs Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Obsessive-Compulsive Disorder Drugs Revenue Market Share, 2017-2028
Figure 33. Turkey Obsessive-Compulsive Disorder Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Obsessive-Compulsive Disorder Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Obsessive-Compulsive Disorder Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Obsessive-Compulsive Disorder Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. Eli Lilly and Co. Obsessive-Compulsive Disorder Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. GlaxoSmithKline Plc Obsessive-Compulsive Disorder Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. H. Lundbeck AS Obsessive-Compulsive Disorder Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Novartis AG Obsessive-Compulsive Disorder Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Pfizer Inc. Obsessive-Compulsive Disorder Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)